Journal of pediatric and adolescent gynecology · 2026
Prescribing Practices for Pre- and Post-Procedural Analgesia During Intrauterine Device Insertion: A National Survey of Providers in the United States.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Friedlich Nicole E, Dunlop Hayley M, Shah Snehi, Combs Shanna M
Аннотация
BACKGROUND: The intrauterine device (IUD) is an effective contraceptive, but insertion pain is a significant concern and barrier, especially for nulliparous patients.
OBJECTIVE: To evaluate differences in practice patterns for pre- and post-procedural analgesia during IUD insertion.
STUDY DESIGN: A cross-sectional national web-based survey of 652 IUD providers examined demographics and their likelihood of prescribing analgesia to nulliparous and multiparous patients. Linear regression models and 1-way analysis of variance (ANOVA) tests assessed differences in analgesia recommendations by provider demographics.
RESULTS: Pre-procedurally, 75.9% of providers for nulliparous and 66.2% for multiparous patients frequently prescribed non-steroidal anti-inflammatory drug (NSAIDs). Post-procedurally, 76.5% for nulliparous and 65.4% for multiparous patients frequently prescribed NSAIDs. Providers with 30+ years of experience and cisgender male providers prescribed NSAIDs and anxiolytics less frequently.
CONCLUSIONS: NSAIDs were the most common analgesic pre- and post-IUD insertion. Prescribing practices varied by gender and years in practice. Providers should adopt patient-centered prescribing to reduce IUD insertion pain.
OBJECTIVE: To evaluate differences in practice patterns for pre- and post-procedural analgesia during IUD insertion.
STUDY DESIGN: A cross-sectional national web-based survey of 652 IUD providers examined demographics and their likelihood of prescribing analgesia to nulliparous and multiparous patients. Linear regression models and 1-way analysis of variance (ANOVA) tests assessed differences in analgesia recommendations by provider demographics.
RESULTS: Pre-procedurally, 75.9% of providers for nulliparous and 66.2% for multiparous patients frequently prescribed non-steroidal anti-inflammatory drug (NSAIDs). Post-procedurally, 76.5% for nulliparous and 65.4% for multiparous patients frequently prescribed NSAIDs. Providers with 30+ years of experience and cisgender male providers prescribed NSAIDs and anxiolytics less frequently.
CONCLUSIONS: NSAIDs were the most common analgesic pre- and post-IUD insertion. Prescribing practices varied by gender and years in practice. Providers should adopt patient-centered prescribing to reduce IUD insertion pain.